Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bar-on

Showing results (441-450 of 556) with videos related to

Pageof 56
Sort By:
Rhinology|August 11, 2023
Impact of azole antifungal treatment on outcome in acute invasive fungal rhinosinusitis with orbitocranial involvement: a surgical perspectiveI Tessler, R Shemesh, G Sherman, et al.
Plos Pathogens|January 12, 2022
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infectionDina Khateeb, Tslil Gabrieli, Bar Sofer, et al.
The Lancet. Infectious Diseases|September 12, 2022
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational studyOfra Amir, Yair Goldberg, Micha Mandel, et al.
Journal of Biomechanics|March 21, 2017
Achilles tendon moment arm length is smaller in children with cerebral palsy than in typically developing childrenBarbara M Kalkman, Lynn Bar-On, Francesco Cenni, et al.
Cell Reports|April 23, 2013
Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza virusesYotam Bar-On, Ariella Glasner, Tal Meningher, et al.
Experimental Physiology|December 28, 2017
Medial gastrocnemius muscle stiffness cannot explain the increased ankle joint range of motion following passive stretching in children with cerebral palsyBarbara M Kalkman, Lynn Bar-On, Francesco Cenni, et al.
The New England Journal of Medicine|April 5, 2022
Protection by a Fourth Dose of BNT162b2 against Omicron in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
Harefuah|December 21, 2023
[TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS]Shay Menascu, Amir Pollak, Yehuda Warszawer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2022
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitorsBarliz Waissengein, Bian Abu Ata, Ofer Merimsky, et al.
Pageof 56

Showing results (441-450 of 556) with videos related to

Sort By:
Pageof 56
Rhinology|August 11, 2023
Impact of azole antifungal treatment on outcome in acute invasive fungal rhinosinusitis with orbitocranial involvement: a surgical perspectiveI Tessler, R Shemesh, G Sherman, et al.
Plos Pathogens|January 12, 2022
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infectionDina Khateeb, Tslil Gabrieli, Bar Sofer, et al.
The Lancet. Infectious Diseases|September 12, 2022
Initial protection against SARS-CoV-2 omicron lineage infection in children and adolescents by BNT162b2 in Israel: an observational studyOfra Amir, Yair Goldberg, Micha Mandel, et al.
Journal of Biomechanics|March 21, 2017
Achilles tendon moment arm length is smaller in children with cerebral palsy than in typically developing childrenBarbara M Kalkman, Lynn Bar-On, Francesco Cenni, et al.
Cell Reports|April 23, 2013
Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza virusesYotam Bar-On, Ariella Glasner, Tal Meningher, et al.
Experimental Physiology|December 28, 2017
Medial gastrocnemius muscle stiffness cannot explain the increased ankle joint range of motion following passive stretching in children with cerebral palsyBarbara M Kalkman, Lynn Bar-On, Francesco Cenni, et al.
The New England Journal of Medicine|April 5, 2022
Protection by a Fourth Dose of BNT162b2 against Omicron in IsraelYinon M Bar-On, Yair Goldberg, Micha Mandel, et al.
Communications Biology|March 24, 2023
Protection against Omicron BA.1/BA.2 severe disease 0-7 months after BNT162b2 boosterOfra Amir, Yair Goldberg, Micha Mandel, et al.
Harefuah|December 21, 2023
[TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS]Shay Menascu, Amir Pollak, Yehuda Warszawer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 27, 2022
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitorsBarliz Waissengein, Bian Abu Ata, Ofer Merimsky, et al.
Pageof 56